Save time and get answers to complex questions with AI chat
How to apply for vascepa's patient assistance?When did risperdal constas patent expire published article?Guselkumab loss of exclusitivy?When will generic fiasap insulin be available?Allergan's patent for latisse expired?
See the DrugPatentWatch profile for Rybelsus
Rybelsus (oral semaglutide) received FDA approval for adults with type 2 diabetes in September 2019. [1]
At approval, Rybelsus was indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. [1]
Approval dates can differ by regulator (e.g., FDA vs. EMA). If you tell me the country (or regulator), I can narrow the date to the relevant label approval.
[1] https://www.drugpatentwatch.com/patent/rybelsus/approval-date
Other Questions About Rybelsus :